No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Established in Beijing, China, in 1998, Cachet Pharmaceutical Co., Ltd. is a prominent Chinese enterprise engaged in the comprehensive wholesale and retail trade of pharmaceutical goods. The company's operations are multifaceted, encompassing the provision of medicines to hospitals, the large-scale distribution of biological products, medical devices, and traditional Chinese remedies. Additionally, it handles pharmaceutical logistics and actively manufactures its own line of medications. In Beijing, Cachet Pharmaceutical maintains a significant retail footprint with 150 chain stores, where customers can find a wide array of products, including pharmaceuticals, health supplements, medical instruments, cosmetics, daily essentials, and traditional Chinese medicines.
www.cachet.com.cnNo one on the platform currently holds 002462.SZ.
No tracked institution reports a position in 002462.SZ as of their last filing.
No one on the platform has traded 002462.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 3.0% | — | — | — | ||
| Rev. Growth % | -18.7% | -3.4% | ||||
| Profit Margin % | 0.6% | 0.9% | 1.3% | |||
| Free Cash Flow Margin % | 7.0% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $18.1B | +26.7% | $1.34 | $1.34–$1.34 | — | 1 |
| 2027 | $21.8B | +21.0% | $1.61 | $1.61–$1.61 | — | 1 |
| 2028 | $28.5B | +30.3% | $2.04 | $2.04–$2.04 | — | 1 |
| 2029 | $30.9B | +8.7% | $2.31 | $2.31–$2.31 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 6 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-04-29 | $0.39 | $0.13 | -67.0% |
| 2026-03-13 | $0.33 | $-0.10 | -130.4% |
| 2025-10-26 | $0.47 | $0.11 | -76.7% |
| 2025-08-29 | $0.41 | $0.21 | -48.7% |
| 2025-04-25 | $0.38 | $0.16 | -57.7% |
| 2025-04-25 | $0.31 | $-0.24 | -176.2% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002462.SZCachet Pharmaceutical Co., Ltd. | $12.14 | +0.50% | $3.5B | — |
| 002758.SZZJAMP Group Co., Ltd. | $8.62 | +1.41% | $4.5B | — |
| 300289.SZBeijing Leadman Biochemistry Co.,Ltd. | $5.67 | +0.35% | $3.1B | — |
| 300314.SZNingbo David Medical Device Co., Ltd. | $11.74 | +5.01% | $3.4B | — |
| 300439.SZMedicalsystem Biotechnology Co., Ltd. |
| $9.43 |
| +0.75% |
| $3.6B |
| — |
| 600833.SSShanghai No.1 Pharmacy Co., Ltd. | $10.16 | +0.40% | $2.3B | — |
| 603309.SSWell Lead Medical Co., Ltd. | $10.66 | -0.00% | $3.1B | — |
Source: Financial Modeling Prep · peers by sector/industry